Table 4 Intermediate precision of Tezacaftor in mobile phase and human plasma
S. no. | Conc (μg/mL) | Mobile phase | Human plasma | ||||
|---|---|---|---|---|---|---|---|
Conc found (μg/mL) | % | Avg % | Conc found (μg/mL) | % | Avg % | ||
1 | 30 | 30.7 | 102.3 | 101.5 | 30.69 | 102.3 | 101.8 |
2 | 30.52 | 101.7 | 30.48 | 101.6 | |||
3 | 30.22 | 100.7 | 30.57 | 101.9 | |||
4 | 30.32 | 101.0 | 30.50 | 101.6 | |||
5 | 30.49 | 101.6 | 30.55 | 101.8 | |||
6 | 30.52 | 101.7 | 30.52 | 101.7 | |||
S.D | 0.021 | 0.03 | |||||
% R.S.D | 0.06 | 0.09 | |||||